PUMA BIOTECHNOLOGY, INC. Investing Cash Flow
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Investing Cash Flow of $10.45 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-06
- PUMA BIOTECHNOLOGY, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $7.97M.
- PUMA BIOTECHNOLOGY, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $2.47M, a 61.59% increase year-over-year.
- PUMA BIOTECHNOLOGY, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$26.98M.
- PUMA BIOTECHNOLOGY, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $506.00K, a 95.37% increase year-over-year.
- PUMA BIOTECHNOLOGY, INC. net cash provided by (used in) investing activities for fiscal 2025 was -$36.19M.
- PUMA BIOTECHNOLOGY, INC. net cash provided by (used in) investing activities for fiscal 2024 was -$20.44M.
- PUMA BIOTECHNOLOGY, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$19.13M, a 369.21% decline from fiscal 2022.
- PUMA BIOTECHNOLOGY, INC. net cash provided by (used in) investing activities for fiscal 2022 was $7.10M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed | Net Cash Provided by (Used in) Investing Activities 16 month | Net Cash Provided by (Used in) Investing Activities 18 month | Net Cash Provided by (Used in) Investing Activities 21 month | Net Cash Provided by (Used in) Investing Activities 25 month | Net Cash Provided by (Used in) Investing Activities 27 month | Net Cash Provided by (Used in) Investing Activities 30 month | Net Cash Provided by (Used in) Investing Activities 33 month | Net Cash Provided by (Used in) Investing Activities 36 month | Net Cash Provided by (Used in) Investing Activities 39 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $7.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $10.45M 10-Q · filed 2026-08-06 | -$16.53M derived: sum of 3 quarters · filed 2026-08-06 | -$16.02M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||||
| 2026-03-31 | $2.47M 10-Q · filed 2026-05-07 | -$24.50M derived: sum of 2 quarters · filed 2026-05-07 | -$24.00M derived: sum of 3 quarters · filed 2026-05-07 | -$35.24M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||||
| 2025-12-31 | -$26.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$26.47M derived: sum of 2 quarters · filed 2026-02-26 | -$37.72M derived: sum of 3 quarters · filed 2026-08-06 | -$36.19M 10-K · filed 2026-02-26 | |||||||||||||
| 2025-09-30 | $506.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$10.74M derived: sum of 2 quarters · filed 2026-08-06 | -$9.21M 10-Q · filed 2025-11-06 | -$11.53M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||||
| 2025-06-30 | -$11.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$9.72M 10-Q · filed 2026-08-06 | -$12.04M derived: sum of 3 quarters · filed 2026-08-06 | -$11.78M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||||
| 2025-03-31 | $1.53M 10-Q · filed 2026-05-07 | -$789.00K derived: sum of 2 quarters · filed 2026-05-07 | -$530.00K derived: sum of 3 quarters · filed 2026-05-07 | $173.00K derived: sum of 4 quarters · filed 2026-05-07 | |||||||||||||
| 2024-12-31 | -$2.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$2.06M derived: sum of 2 quarters · filed 2026-02-26 | -$1.36M derived: sum of 3 quarters · filed 2026-02-26 | -$20.44M 10-K · filed 2026-02-26 | |||||||||||||
| 2024-09-30 | $259.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $962.00K derived: sum of 2 quarters · filed 2025-11-06 | -$18.12M 10-Q · filed 2025-11-06 | -$26.29M derived: sum of 4 quarters · filed 2026-02-26 | |||||||||||||
| 2024-06-30 | $703.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$18.38M 10-Q · filed 2025-08-07 | -$26.55M derived: sum of 3 quarters · filed 2026-02-26 | -$15.37M derived: sum of 4 quarters · filed 2026-02-26 | |||||||||||||
| 2024-03-31 | -$19.08M 10-Q · filed 2025-05-08 | -$27.25M derived: sum of 2 quarters · filed 2026-02-26 | -$16.07M derived: sum of 3 quarters · filed 2026-02-26 | -$20.75M derived: sum of 4 quarters · filed 2026-02-26 | |||||||||||||
| 2023-12-31 | -$8.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.01M derived: sum of 2 quarters · filed 2026-02-26 | -$1.68M derived: sum of 3 quarters · filed 2026-02-26 | -$19.13M 10-K · filed 2026-02-26 | |||||||||||||
| 2023-09-30 | $11.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $6.50M derived: sum of 2 quarters · filed 2024-11-07 | -$10.96M 10-Q · filed 2024-11-07 | -$22.83M derived: sum of 4 quarters · filed 2025-02-27 | |||||||||||||
| 2023-06-30 | -$4.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$22.13M 10-Q · filed 2024-08-01 | -$34.01M derived: sum of 3 quarters · filed 2025-02-27 | -$26.01M derived: sum of 4 quarters · filed 2025-02-27 | |||||||||||||
| 2023-03-31 | -$17.45M 10-Q · filed 2024-05-02 | -$29.32M derived: sum of 2 quarters · filed 2025-02-27 | -$21.32M derived: sum of 3 quarters · filed 2025-02-27 | -$19.33M derived: sum of 4 quarters · filed 2025-02-27 | |||||||||||||
| 2022-12-31 | -$11.87M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$3.88M derived: sum of 2 quarters · filed 2025-02-27 | -$1.88M derived: sum of 3 quarters · filed 2025-02-27 | $7.10M 10-K · filed 2025-02-27 | |||||||||||||
| 2022-09-30 | $8.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $9.99M derived: sum of 2 quarters · filed 2023-11-02 | $18.98M 10-Q · filed 2023-11-02 | $23.60M derived: sum of 4 quarters · filed 2024-02-29 | |||||||||||||
| 2022-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $10.98M 10-Q · filed 2023-08-03 | $15.60M derived: sum of 3 quarters · filed 2024-02-29 | $11.13M derived: sum of 4 quarters · filed 2024-02-29 | |||||||||||||
| 2022-03-31 | $8.98M 10-Q · filed 2023-05-04 | $13.60M derived: sum of 2 quarters · filed 2024-02-29 | $9.13M derived: sum of 3 quarters · filed 2024-02-29 | $3.40M derived: sum of 4 quarters · filed 2024-02-29 | |||||||||||||
| 2021-12-31 | $4.62M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $151.00K derived: sum of 2 quarters · filed 2024-02-29 | -$5.58M derived: sum of 3 quarters · filed 2024-02-29 | -$10.88M 10-K · filed 2024-02-29 | |||||||||||||
| 2021-09-30 | -$4.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$10.20M derived: sum of 2 quarters · filed 2022-11-03 | -$15.50M 10-Q · filed 2022-11-03 | -$4.68M derived: sum of 4 quarters · filed 2023-03-02 | |||||||||||||
| 2021-06-30 | -$5.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$11.03M 10-Q · filed 2022-08-04 | -$209.00K derived: sum of 3 quarters · filed 2023-03-02 | -$2.79M derived: sum of 4 quarters · filed 2023-03-02 | |||||||||||||
| 2021-03-31 | -$5.30M 10-Q · filed 2022-05-05 | $5.52M derived: sum of 2 quarters · filed 2023-03-02 | $2.94M derived: sum of 3 quarters · filed 2023-03-02 | -$6.28M derived: sum of 4 quarters · filed 2023-03-02 | |||||||||||||
| 2020-12-31 | $10.82M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $8.24M derived: sum of 2 quarters · filed 2023-03-02 | -$974.00K derived: sum of 3 quarters · filed 2023-03-02 | $33.40M 10-K · filed 2023-03-02 | $23.40M 10-K · filed 2021-03-01 | ||||||||||||
| 2020-09-30 | -$2.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$11.80M derived: sum of 2 quarters · filed 2021-11-04 | $22.58M 10-Q · filed 2021-11-04 | $22.15M derived: sum of 4 quarters · filed 2022-03-03 | |||||||||||||
| 2020-06-30 | -$9.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $25.16M 10-Q · filed 2021-08-05 | $24.73M derived: sum of 3 quarters · filed 2022-03-03 | $63.70M derived: sum of 4 quarters · filed 2022-03-03 | |||||||||||||
| 2020-03-31 | $34.38M 10-Q · filed 2021-05-06 | $33.95M derived: sum of 2 quarters · filed 2022-03-03 | $72.92M derived: sum of 3 quarters · filed 2022-03-03 | $84.12M derived: sum of 4 quarters · filed 2022-03-03 | |||||||||||||
| 2019-12-31 | -$432.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $38.54M derived: sum of 2 quarters · filed 2022-03-03 | $49.75M derived: sum of 3 quarters · filed 2022-03-03 | $5.16M 10-K · filed 2022-03-03 | |||||||||||||
| 2019-09-30 | $38.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $50.18M derived: sum of 2 quarters · filed 2020-11-05 | $5.59M 10-Q · filed 2020-11-05 | $8.18M derived: sum of 4 quarters · filed 2021-03-01 | |||||||||||||
| 2019-06-30 | $11.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$33.38M 10-Q · filed 2020-08-06 | -$30.80M derived: sum of 3 quarters · filed 2021-03-01 | -$52.16M derived: sum of 4 quarters · filed 2021-03-01 | |||||||||||||
| 2019-03-31 | -$44.58M 10-Q · filed 2020-05-07 | -$42.00M derived: sum of 2 quarters · filed 2021-03-01 | -$63.36M derived: sum of 3 quarters · filed 2021-03-01 | -$102.17M derived: sum of 4 quarters · filed 2021-03-01 | |||||||||||||
| 2018-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$18.78M derived: sum of 2 quarters · filed 2021-03-01 | -$57.58M derived: sum of 3 quarters · filed 2021-03-01 | -$57.62M 10-K · filed 2021-03-01 | |||||||||||||
| 2018-09-30 | -$21.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$60.16M derived: sum of 2 quarters · filed 2019-11-07 | -$60.20M 10-Q · filed 2019-11-07 | -$83.72M derived: sum of 4 quarters · filed 2020-02-28 | |||||||||||||
| 2018-06-30 | -$38.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$38.84M 10-Q · filed 2019-08-09 | -$62.36M derived: sum of 3 quarters · filed 2020-02-28 | -$18.29M derived: sum of 4 quarters · filed 2020-02-28 | |||||||||||||
| 2018-03-31 | -$40.00K 10-Q · filed 2019-05-10 | -$23.56M derived: sum of 2 quarters · filed 2020-02-28 | $20.52M derived: sum of 3 quarters · filed 2020-02-28 | ||||||||||||||
| 2017-12-31 | -$23.52M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $20.56M derived: sum of 2 quarters · filed 2020-02-28 | -$15.44M 10-K · filed 2020-02-28 | ||||||||||||||
| 2017-09-30 | $44.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $8.08M 10-Q · filed 2018-11-05 | |||||||||||||||
| 2017-06-30 | -$35.99M 10-Q · filed 2018-08-09 | ||||||||||||||||
| 2016-12-31 | $142.19M 10-K · filed 2019-03-01 | ||||||||||||||||
| 2013-12-31 | $3.29M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $5.52M derived: sum of 2 quarters · filed 2014-03-03 | -$14.25M derived: sum of 3 quarters · filed 2014-03-03 | -$41.53M 10-K · filed 2014-03-03 | -$44.50M 10-K · filed 2014-03-03 | ||||||||||||
| 2013-09-30 | $2.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$17.55M derived: sum of 2 quarters · filed 2013-11-12 | -$44.82M 10-Q · filed 2013-11-12 | -$45.21M derived: sum of 4 quarters · filed 2014-03-03 | -$47.79M 10-Q · filed 2013-11-12 | ||||||||||||
| 2013-06-30 | -$19.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | -$47.05M 10-Q · filed 2013-08-06 | -$47.44M derived: sum of 3 quarters · filed 2014-03-03 | -$47.45M derived: sum of 4 quarters · filed 2014-03-03 | -$50.02M 10-Q · filed 2013-08-06 | ||||||||||||
| 2013-03-31 | -$27.28M 10-Q · filed 2013-05-09 | -$27.67M derived: sum of 2 quarters · filed 2014-03-03 | -$27.68M derived: sum of 3 quarters · filed 2014-03-03 | -$28.08M derived: sum of 4 quarters · filed 2014-03-03 | -$30.25M 10-Q · filed 2013-05-09 | ||||||||||||
| 2012-12-31 | -$389.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | -$400.00K derived: sum of 2 quarters · filed 2014-03-03 | -$797.00K derived: sum of 3 quarters · filed 2014-03-03 | -$1.22M 10-K · filed 2014-03-03 | -$2.97M 10-K · filed 2013-04-01 | ||||||||||||
| 2012-09-30 | -$11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$408.00K derived: sum of 2 quarters · filed 2013-11-12 | -$832.00K 10-Q · filed 2013-11-12 | -$832.47K 10-Q · filed 2012-11-14 | -$2.57M derived: sum of 4 quarters · filed 2014-03-03 | -$2.58M 10-Q · filed 2012-11-14 | |||||||||||
| 2012-06-30 | -$397.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | -$821.00K 10-Q · filed 2013-08-06 | -$821.12K 10-Q · filed 2012-08-14 | -$2.56M derived: sum of 3 quarters · filed 2014-03-03 | -$2.56M derived: sum of 4 quarters · filed 2014-03-03 | -$2.57M 10-Q · filed 2012-08-14 | |||||||||||
| 2012-03-31 | -$424.00K 10-Q · filed 2013-05-09 | -$424.23K 10-Q · filed 2012-05-15 | -$2.17M derived: sum of 2 quarters · filed 2014-03-03 | -$2.17M derived: sum of 3 quarters · filed 2014-03-03 | -$2.17M 10-Q · filed 2012-05-15 | ||||||||||||
| 2011-12-31 | -$1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | -$1.74M derived: sum of 2 quarters · filed 2014-03-03 | -$1.75M 10-K · filed 2014-03-03 | -$1.75M 10-K · filed 2012-03-29 | -$1.75M 10-K · filed 2012-03-29 | ||||||||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | -$3.36K 10-Q · filed 2012-11-14 | |||||||||||||||
| 2011-06-30 | -$3.36K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |